Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.82 +0.94 (+2.42%)
As of: Sep 29, 2026 · 3:59 PM EDT

Teva Pharmaceutical Industries (TEVA) Non-Current Debt (2009 - 2026)

Updated

Teva Pharmaceutical Industries (TEVA) reported Non-Current Debt of $12.09 billion for Q2 2026, down 27.9% from $16.76 billion a year earlier and down 13.7% from the prior quarter.

Analysis

Teva Pharmaceutical Industries (TEVA) Non-Current Debt (2009 - 2026) Analysis & Trends

At the end of FY2025, Teva Pharmaceutical Industries posted Non-Current Debt of $14.99 billion, down 6.3% from FY2024.

  • Non-Current Debt has declined for nine consecutive years, with a five-year compound annual growth rate of -8.0% (FY2020 to FY2025).
  • By year, Non-Current Debt came in at $16 billion in FY2024 (-11.9%), $18.16 billion in FY2023 (-4.9%), $19.1 billion in FY2022 (-11.6%) and $21.62 billion in FY2021 (-4.9%).
  • The Q2 2026 figure ranks as the lowest quarterly Non-Current Debt since Q2 2016.
  • Year over year, Non-Current Debt has now declined in each of the last three quarters, with an average decline of 8.7% over the last eight quarters.
  • The high point for year-over-year Non-Current Debt in five years was Q3 2025 (growth of 2.2%); the low point was Q2 2026 (a decline of 27.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $14.02 billion (Q1 2026), $14.99 billion (Q4 2025) and $16.77 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Teva Pharmaceutical Industries 45.31 Bn 32.16 Bn 2.15 Bn 12.09 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.09 Bn
Mar 31, 2026 14.02 Bn
Dec 31, 2025 14.99 Bn
Sep 30, 2025 16.77 Bn
Jun 30, 2025 16.76 Bn
Mar 31, 2025 16.23 Bn
Dec 31, 2024 16.00 Bn
Sep 30, 2024 16.40 Bn
Jun 30, 2024 16.55 Bn
Mar 31, 2024 16.58 Bn
Dec 31, 2023 18.16 Bn
Sep 30, 2023 18.50 Bn
Jun 30, 2023 18.70 Bn
Mar 31, 2023 19.67 Bn
Dec 31, 2022 19.10 Bn
Sep 30, 2022 18.50 Bn
Jun 30, 2022 20.36 Bn
Mar 31, 2022 20.84 Bn
Dec 31, 2021 21.62 Bn
Sep 30, 2021 21.04 Bn
API Access

Teva Pharmaceutical Industries Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TEVA&period=max&api_key=YOUR_API_KEY